Who Paid My Doc
CT-388-104 OW/OB with T2D
Research payments
$10,984,040
Through program year 2025, $10,984,040 in research payments was reported against CT-388-104 OW/OB with T2D, across 1,625 payments.
- Paid by (largest first)
- Genentech, Inc.; F. Hoffmann-La Roche AG; Hoffmann-La Roche Limited
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $10,984,040 | 1,625 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Rasha Youssef Boca Raton, FL Named on 157 payments
- Jorge Serje Brooklyn, NY Named on 79 payments
- Rizwana Mohseni Montclair, CA Named on 54 payments
- Timothy Bailey Rancho Santa Fe, CA Named on 53 payments
- Arvind Krishna Canton, OH Named on 50 payments
- Sylvia Shoffner Cary, NC Named on 45 payments
- Damaris Vega Houston, TX Named on 44 payments
- Shuyao Zhang Dallas, TX Named on 43 payments
- Joseph Moran Statesville, NC Named on 42 payments
- David Browder Rocky Mount, NC Named on 42 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.